The mifepristone studies were detracted due to flaws in the research and undiscl...
Gilead will no longer develop magrolimab, a treatment targeting the “don’t eat m...
Today’s hearing, led by Sen. Bernie Sanders, will be a crucial test for a new ge...
The European Medicines Agency will investigate any risks to the availability of ...
What is the relationship between aging, memory loss, and overall cognition? That...
Aurobindo, one of the largest generic drug makers, has halted some production at...
A bipartisan group of senators is starting to work on long-term fixes to issues ...
Follow-up data from Moderna’s Phase 3 RSV vaccine trial reveals that its efficac...
A medical journal has retracted two studies claiming to show the harms of the ab...
Verekitug is under clinical development by Upstream Bio and currently in Phase I...
Tapotoclax is under clinical development by Amgen and currently in Phase I for M...
Tapotoclax is under clinical development by Amgen and currently in Phase I for C...
Vorolanib is under clinical development by EyePoint Pharmaceuticals and currentl...
Monoclonal Antibody Conjugate 3 to Target EGFR for Oncology is under clinical de...
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...
(Edetate disodium + ethyl alcohol + minocycline hydrochloride) is under clinical...
